Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03001765 · ClinicalTrials.gov registry record · NA
Impact of an Intensive Monitoring Strategy in Symptomatic Patients With Suspected Arrhythmia
A NA study of Suspected Arrhythmia, sponsored by St Elizabeth Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT03001765: Completed NA study of Suspected Arrhythmia, sponsored by St Elizabeth Healthcare.
NCT03001765 is a NA study of Suspected Arrhythmia that has completed, run by St Elizabeth Healthcare. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03001765, a NA study of Suspected Arrhythmia, has completed, sponsored by St Elizabeth Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypothesis: Patients that were previously discharged from the emergency department with a subsequent non-diagnostic 30 day external patch monitor for suspected arrhythmia will benefit from early Reveal LINQ™ Insertable Cardiac Monitoring System placement. Primary Study Objectives: To evaluate the outcome of an intensive monitoring strategy (patients with a negative 30 day SEEQ™ Mobile Cardiac Telemetry (MCT) System result are purposed over for a Reveal LINQ™ Insertable Cardiac Monitoring System) in patients with suspected but no previously documented arrhythmias that result in a clinically actionable event.
Primary Outcome
The number of subjects in which any cardiac arrhythmia that results in a clinically actionable event will be recorded. Descriptive statistics will be used to describe baseline study subject characteristics and the clinically actionable findings.
Conditions Studied
Interventions
- OTHER Intensive Monitoring Strategy: Reveal LINQ™ Insertable Cardiac Monitoring System".
Study Locations (1)
Kentucky
- St. Elizabeth Healthcare - Edgewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-09 |
| Phase | NA |
What the finished NCT03001765 record still lists
NCT03001765 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Suspected Arrhythmia appearing as the primary indexed condition, and to 1 intervention - of which Intensive Monitoring Strategy: Reveal LINQ™ Insertable Cardiac Monitoring System". is the first listed.
NCT03001765 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT03001765 about?
NCT03001765 is a clinical study titled "Impact of an Intensive Monitoring Strategy in Symptomatic Patients With Suspected Arrhythmia". Hypothesis: Patients that were previously discharged from the emergency department with a subsequent non-diagnostic 30 day external patch monitor for suspected arrhythmia will benefit from early Reveal LINQ™ Insertable Cardiac Monitoring System placement. Primary Study Objectives: To evaluate the...
What is the current status of trial NCT03001765?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2016-12. Estimated completion is 2018-09.
What conditions does trial NCT03001765 study?
This clinical trial studies the following conditions: Suspected Arrhythmia.
What interventions are being tested in trial NCT03001765?
The interventions under investigation include: Intensive Monitoring Strategy: Reveal LINQ™ Insertable Cardiac Monitoring System". (OTHER).
Who is sponsoring clinical trial NCT03001765?
This trial is sponsored by St Elizabeth Healthcare, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03001765 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03001765's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia